DrugPatentWatch Database Preview

Cadila Pharms Ltd Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CADILA PHARMS LTD, and what generic and branded alternatives to CADILA PHARMS LTD drugs are available?

CADILA PHARMS LTD has twenty-four approved drugs.

There is one tentative approval on CADILA PHARMS LTD drugs.

Summary for Cadila Pharms Ltd

US Patents:	0
Tradenames:	22
Ingredients:	22
NDAs:	24

Drugs and US Patents for Cadila Pharms Ltd

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cadila Pharms Ltd	VENLAFAXINE HYDROCHLORIDE	venlafaxine hydrochloride	TABLET;ORAL	206250-005	Nov 21, 2018	AB	RX	No	No
Cadila Pharms Ltd	FLUOXETINE HYDROCHLORIDE	fluoxetine hydrochloride	CAPSULE;ORAL	206993-002	May 23, 2019	AB1	RX	No	No
Cadila Pharms Ltd	PAROXETINE HYDROCHLORIDE	paroxetine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	212645-001	Aug 27, 2021	AB	RX	No	No
Cadila Pharms Ltd	ROSUVASTATIN CALCIUM	rosuvastatin calcium	TABLET;ORAL	207453-002	Nov 23, 2016	AB	RX	No	No
Cadila Pharms Ltd	RIVASTIGMINE TARTRATE	rivastigmine tartrate	CAPSULE;ORAL	203844-001	Feb 13, 2017	AB	RX	No	No
Cadila Pharms Ltd	RALOXIFENE HYDROCHLORIDE	raloxifene hydrochloride	TABLET;ORAL	211324-001	Aug 18, 2020	AB	RX	No	No
Cadila Pharms Ltd	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	203845-002	Sep 18, 2014	AA	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Cadila
• Cadila Pharms Ltd